3-((1-(3-((2-oxo-2H-chromen-7-yl)oxy)propyl)-1H-1,2,3-triazol-4-yl)methoxy)benzaldehyde

ID: ALA4475016

PubChem CID: 155537404

Max Phase: Preclinical

Molecular Formula: C22H19N3O5

Molecular Weight: 405.41

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=Cc1cccc(OCc2cn(CCCOc3ccc4ccc(=O)oc4c3)nn2)c1

Standard InChI:  InChI=1S/C22H19N3O5/c26-14-16-3-1-4-19(11-16)29-15-18-13-25(24-23-18)9-2-10-28-20-7-5-17-6-8-22(27)30-21(17)12-20/h1,3-8,11-14H,2,9-10,15H2

Standard InChI Key:  NVNIDGYSZZAEON-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   35.9055  -23.6118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9043  -24.4314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.6124  -24.8403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.6106  -23.2030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.3192  -23.6082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.3180  -24.4289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.0242  -24.8379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.7361  -24.4309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.7373  -23.6102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.0266  -23.1966    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.1977  -23.2034    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   39.4460  -23.2034    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.4901  -23.6122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7822  -23.2037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0746  -23.6125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3668  -23.2041    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.2805  -22.3927    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.4811  -22.2230    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.0726  -22.9309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6197  -23.5379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2526  -22.9309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8440  -22.2232    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.0268  -22.2232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6211  -21.5150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8047  -21.5147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3953  -22.2229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8083  -22.9330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6234  -22.9298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4022  -23.6421    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5850  -23.6450    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
  1 11  1  0
  9 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 16  1  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 27 29  1  0
 29 30  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4475016

    ---

Associated Targets(Human)

HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA12 Tclin Carbonic anhydrase XII (6231 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA9 Tclin Carbonic anhydrase IX (8255 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA2 Tclin Carbonic anhydrase II (17698 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA1 Tclin Carbonic anhydrase I (13240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 405.41Molecular Weight (Monoisotopic): 405.1325AlogP: 3.25#Rotatable Bonds: 9
Polar Surface Area: 96.45Molecular Species: NEUTRALHBA: 8HBD:
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 2.90CX LogD: 2.90
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.24Np Likeness Score: -0.92

References

1. Zengin Kurt B, Sonmez F, Ozturk D, Akdemir A, Angeli A, Supuran CT..  (2019)  Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies.,  183  [PMID:31542715] [10.1016/j.ejmech.2019.111702]

Source